EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH

View source ↗

Summary

Zutectra, a human hepatitis B immunoglobulin product by Biotest Pharma GmbH, has been authorised for use in immunization and passive immunity contexts, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Transplantation

Drugs mentioned

• Zutectra (human hepatitis B immunoglobulin)

Snippet

Status: Authorised. Therapeutic area: Immunization, Passive;Hepatitis B;Liver Transplantation. MAH: Biotest Pharma GmbH. Decision date: 21/05/2026